{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-24-034440","form_type":"8-K","ticker":"ADMA","cik":"0001368514","company_name":"ADMA BIOLOGICS, INC.","filed_at":"2024-07-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.801621+00:00","generated_at":"2026-05-31T15:56:08.762648+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"ADMA Biologics promotes Brad Tade to CFO and Treasurer, effective July 24, 2024","bullets":["Brad Tade, former VP Financial Operations, promoted to CFO and Treasurer effective July 24, 2024.","Base salary set at $435,000 annually; target bonus of 45% of base salary.","Granted 115,100 stock options and 72,400 RSUs, each vesting over four years.","Severance includes 12 months base salary; 15 months plus 1.5x target bonus if within one year of change of control.","Tade joined ADMA in June 2023; prior roles at Baxter International and Becton Dickinson."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-24-034440","json":"https://secwatch.observer/filing/0001140361-24-034440.json","markdown":"https://secwatch.observer/filing/0001140361-24-034440.md","text":"https://secwatch.observer/filing/0001140361-24-034440.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1368514/000114036124034440/0001140361-24-034440-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1368514/000114036124034440/ef20033085_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T15:56:08.762648+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a04bddc714","claim":"Brad Tade changed role as Chief Financial Officer and Treasurer at ADMA BIOLOGICS, INC..","evidence_excerpt":"Brad Tade, former Vice President, Financial Operations of ADMA Biologics, Inc. (the \"Company\"), was promoted to Chief Financial Officer and Treasurer of the Company","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1368514/000114036124034440/0001140361-24-034440-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"promoted"},{"label":"Role","value":"Chief Financial Officer and Treasurer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}